Leukemia Research
Volume 33, Issue 11 , Pages 1452-1453 , November 2009

Just exactly how common is CLL?

Received 3 July 2009

References 

  1. Hansen MM. Chronic Lymphocytic Leukaemia: clinical studies based on 189 cases followed for a long time. Scand J Haematol. 1973;(Suppl. 18):1–286
  2. Sgambati MT, Linet MS, Devesa SS. Chronic lymphocytic leukemia: epidemiological, familial, and genetic aspects. In:  Cheson BD editors. Chronic lymphoid leukemias; second edition revised and expanded. New York: Marcel Dekker Inc.; 1991;p. 33–62
  3. Cartwright RA, Alexander FE, McKinney PA, Ricketts TJ. Leukaemia and lymphoma: an atlas of distribution within areas of England and Wales 1984-1988. London: Leukemia Research Fund; 1990;
  4. Cheson BD, Bennett JM, Rai KR, et al. Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group. Am J Hematol. 1988;29:152–163
  5. International Workshop on Chronic Lymphocytic Leukemia: recommendations for diagnosis, staging, and response criteria. Ann Intern Med 1989;110:236.
  6. Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996;87:4990–4997
  7. Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111:5446–5456
  8. Rawstron AC, Green MJ, Kuzmicki A, et al. Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood. 2002;100:635–639
  9. Nieto WG, Almeida J, Romero A, et al. Increased frequency (12%) of circulating CLL-like B-cell clones in healthy individuals using a high-sensitive multicolor flow cytometry approach. Prepublished online May 6, 2009;doi:10.1182/blood-2009-01-197368 Accessed July 3rd 2009.
  10. Ladgren O, Albitar M, Wanlong M, et al. B cell clones as early markers for Chronic Lymphocytic Leukemia. N Engl J Med. 2009;360:659–667
  11. Seftel MD, Demmers AA, Banerji V, et al. High incidence of chronic lymphocytic leukema (CLL) diagnosed by immunophenotyping: a population-based Canadian cohort. Leuk Res 2009 [this issue full details awaited].
  12. Dores GM, Anderson WF, Curtis RE, et al. Chronic lymphocytic leukaemia and small lymphocytic leukaemia: overview of the descriptive epidemiology. Br J Haematol. 2007;139:809–819
  13. Public Health Agency of Canada. Cancer Surveillance Online. Available from URL: http://dsol-smed.phac-aspc.gc.ca/dsol-smed/cancer/index_e.html 2009 Accessed July 2nd 2009.
  14. Hoffbrand AV, Hamblin TJ. Is “Leukemia” an appropriate label for all patients who meet the diagnostic criteria of chronic lymphocytic leukemia?. Leuk Res. 2007;31:273–275
  15. Shanafelt TD, Kay NE, Jenkins G, et al. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. Blood. 2009;113:4188–4196
  16. Hanson CA, Kurtin PJ, Dogan A. The proposed diagnostic criteria change for chronic lymphocytic leukaemia: unintended consequences. Blood. 2009;113:6495–6496
  17. Mulligan CS, Thomas ME, Mulligan SP. Lymphocytes, B lymphocytes, and clonal CLL cells: observations on the impact of the new diagnostic criteria in the 2008 guidelines for Chronic Lymphocytic Leukemia (CLL). Blood. 2009;113:6496–6497
  18. Hillmen P, Cheson BD, Catovsky D, et al. Letters regarding Blood 2009;113:6495–7 by Hanson et al. and Mulligan et al. Blood 2009;113:6497–8.

PII: S0145-2126(09)00358-0

doi: 10.1016/j.leukres.2009.07.005

Leukemia Research
Volume 33, Issue 11 , Pages 1452-1453 , November 2009

Article Tools